13.42 USD
▼+0.30-0.37%
盘后 13.73 +1.93%
2026-08-03
市值
$1.12B
市盈率
33.29
EPS
0.40
股息率
—
52 周区间
5.81 – 14.00
成交量
947.24K
Beta
0.65
目标价
14.80
52W 低 5.8152W 高 14.00
价格走势
公司简介
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a ...